Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Accumulated Expenses (2018 - 2024)

Neuroone Medical Technologies filings provide 5 years of Other Accumulated Expenses readings, the most recent being $258244.0 for Q4 2024.

  • On a quarterly basis, Other Accumulated Expenses rose 2482.44% to $258244.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $258244.0, a 2482.44% increase, with the full-year FY2024 number at $59950.0, changed N/A from a year prior.
  • Other Accumulated Expenses hit $258244.0 in Q4 2024 for Neuroone Medical Technologies, up from $59950.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $258244.0 in Q4 2024 to a low of $10000.0 in Q4 2023.
  • Median Other Accumulated Expenses over the past 5 years was $71551.0 (2021), compared with a mean of $98588.5.
  • Biggest five-year swings in Other Accumulated Expenses: plummeted 83.6% in 2022 and later surged 2482.44% in 2024.
  • Neuroone Medical Technologies' Other Accumulated Expenses stood at $218125.0 in 2020, then plummeted by 61.88% to $83152.0 in 2021, then plummeted by 73.54% to $22001.0 in 2022, then crashed by 54.55% to $10000.0 in 2023, then surged by 2482.44% to $258244.0 in 2024.
  • The last three reported values for Other Accumulated Expenses were $258244.0 (Q4 2024), $59950.0 (Q3 2024), and $17007.0 (Q1 2024) per Business Quant data.